EYE » Topics » Nominees for Election as Directors - Term Expiring 2009
This excerpt taken from the EYE DEF 14A filed Apr 20, 2006.
for Election as Directors Term Expiring 2009
William J. Link, Ph.D. Class I
Director since June 2002
Audit and Finance; Science and Technology (Chairman)
Dr. Link is Managing Director and a co-founder
of Versant Ventures, a venture capital firm located in Newport Beach, California
investing in early-stage health care companies. Prior to co-founding Versant
Ventures in 1999, Dr. Link was a general partner at Brentwood Venture
Capital, where he invested in a number of early-stage companies. From 1986 to
1997, Dr. Link was Chairman and Chief Executive Officer of Chiron
Vision, a subsidiary of Chiron Corporation founded by Dr. Link, which
specialized in ophthalmic surgical products and which was later sold to
Bausch and Lomb in 1997. Prior to Chiron Vision, Dr. Link founded and
served as President of American Medical Optics, a division of American
Hospital Supply Corporation, which was sold to Allergan in 1986. Before
entering the health care industry, Dr. Link was an assistant professor
in the Department of Surgery at the Indiana University School of Medicine.
Dr. Link currently serves on the Board of Directors of Intralase
Corporation. Dr. Link earned his bachelors, masters and doctorate
degrees in mechanical engineering from Purdue University.
Michael A. Mussallem Class I
Director since June 2002
Organization, Compensation and Corporate Governance (Chairman); Science and
Mr. Mussallem is
the Chairman of the Board and Chief Executive Officer of Edwards Lifesciences
Corporation, a position he has held since 2000, when Edwards Lifesciences was
spun off from Baxter International, Inc. Mr. Mussallem joined
Baxter in 1979 and was the Group Vice President of Baxters CardioVascular
business from 1994 to 2000 and Group Vice President of Baxters Biopharmaceutical
business from 1998 to 2000. In addition to serving on the Board of Edwards
Lifesciences, Mr. Mussallem serves on the Boards of AdvaMed (Advanced
Medical Technology Association) and the California Healthcare Institute.
Deborah J. Neff Class I
Director since July 2003
Audit and Finance; Science and Technology
Ms. Neff is the
President and Chief Executive Officer of Predicant Biosciences, Inc.
(formerly Biospect, Inc.), which she joined in 2003. Prior to joining
Predicant, from 1988 to 2003, Ms. Neff held a number of executive
positions at Becton Dickinson and Company, a $4 billion global medical
technology and device company. Most recently, from 2000 to 2003, she was
Worldwide President of Becton Dickinson Biosciences, and from 1995 to 2000,
she was President of the Biosciences and Microbiology Systems as well as the
Becton Dickinson Immunocytometry Systems. Before joining Becton Dickinson,
Ms. Neff held senior management positions with Organon-Teknicka Corporation
and CooperBiomedical. In addition to serving on the Board of Predicant,
Ms. Neff is a member of the Advisory Board of the Healthcare
Businesswomens Association, and a member of the Board of Directors of
ForteBio, a private life science company.
How risky is your portfolio?
Remember that 401k from 2 jobs ago?
Taking on too much risk? Too little risk? Have no idea?
Skip the spreadsheet. Track your investments automatically.
We tally your portfolio fees so you don't have to.
You're probably paying higher fees than you think.
Translate your investment accounts from Martian to English.